Evaluation of Anti-Xa Levels in Surgery Patients Receiving Fixed Dose Heparin



Status:Active, not recruiting
Conditions:Cardiology, Cardiology, Cardiology, Cardiology, Cardiology, Cardiology
Therapuetic Areas:Cardiology / Vascular Diseases
Healthy:No
Age Range:18 - Any
Updated:10/28/2017
Start Date:November 10, 2016
End Date:December 8, 2017

Use our guide to learn which trials are right for you!

The purpose of this study is to determine if fixed dose heparin infusions at a rate of 500
units/hour are sufficient to maintain a target anti-Xa of 0.1-0.35 IU/mL for VTE prophylaxis
in patients undergoing microvascular surgery. Additionally, a pilot protocol has been
developed to titrate these heparin infusions to ensure patients have sufficient VTE
prophylaxis. All patients will be enrolled in the observational arm of the study and receive
anti-Xa level monitoring. Patients with out-of-range anti-Xa levels will cross over to the
interventional arm of the study and receive real time heparin infusion dose adjustments per
the pilot protocol. The primary outcome measured will be the percentage of patients with
anti-Xa levels in the target range of 0.1-0.35 IU/mL while on a heparin infusion at 500
units/hour.


Inclusion Criteria:

- Patients undergoing surgical procedures

- Initiation of a heparin infusion at a rate of 500 units/hour intraoperatively or
postoperatively

Exclusion Criteria:

- Age <18 years old

- Pregnant

- Incarcerated

- Mentally disabled
We found this trial at
1
site
50 North Medical Drive
Salt Lake City, Utah 84132
?
mi
from
Salt Lake City, UT
Click here to add this to my saved trials